MilliporeSigma and Baylor College of Medicine have announced they are working to advance a vaccine manufacturing platform to fight COVID-19. The partnership will help accelerate the vaccine candidates to phase I clinical trials.
Biopharmaceutical contract development and manufacturing firm Ajinomoto has entered into an agreement with Humanigen for the fill-finish supply of lenzilumab. The drug is being studied in a phase III clinical trial for adult patients hospitalized with COVID-19.
Thermo Fisher Scientific has entered into a long-term lease agreement with CSL to operate a new biologics manufacturing facility in Lengnau, Switzerland.
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp up a variety of biologics. The strong demand for bioprocessed medicines in 2020 will continue to drive growth of the industry. Discuss
Merck announced on May 26 that it has entered an agreement to acquire privately held Themis, a company that is developing a vaccine candidate for SARS-CoV-2.
Novasep and Lysogene announced that the parties have inked an agreement for the development and manufacturing of an adeno-associated viral vector-based gene therapy drug candidate (LYS-GM101) for the treatment of GM1 gangliosidosis, a neuronopathic lysosomal storage disorder.
Merck and IAVI, a nonprofit scientific research organization, announced that they are partnering to develop a recombinant vesicular stomatitis virus vaccine candidate against SARS-CoV-2.
AbCellera Biologics has joined forces with Eli Lilly on a multiyear initiative to identify antibodies for up to nine therapeutic targets.
Clinical-stage biopharmaceutical company IMV has announced that it is moving forward with a vaccine against the novel coronavirus to test in clinical trials.
In the fight against COVID-19, AGC Biologics, a contract development and manufacturing organization, is partnering with Takara Bio to manufacture plasmid DNA intermediates for a DNA SARS-CoV-2 vaccine, according to the firms.
Conferences
AACR Virtual Annual Meeting 2020 II
June 22-24
June 22-24
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
August 10-13
Santa Clara, California United States
|
General Discussion
|
||
| Topic | Replies / Views | Last Update |
|---|---|---|
|
https://academic.oup.com/ve/pages/coronavirus-evolution
|
0 / 29 | More than 3 days ago |
|
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
|
0 / 11 | More than 3 days ago |
|
Engineered Bacteria Produces BeeFree Honey
|
0 / 12 | More than 3 days ago |
|
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
|
0 / 15 | More than 3 days ago |
|
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
|
0 / 14 | More than 3 days ago |
| To see more posts from our community or to share a post of your own, go to our community's forum page. | ||
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
